X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP)

Experimental Hematology

Volumn 31, Issue 2, 2003, Pages 150-158

  Luthi, Jennifer N ^a   Gandhi, Manish J ^a,b   Drachman, Jonathan G ^a,b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; GLUTAMIC ACID; MUTANT PROTEIN; PROLINE; PROTEIN; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN INTERACTING PROTEIN;

ADULT; ARTICLE; CASE REPORT; CELL MATURATION; CELL SIZE; CYTOPLASM; DISEASE SEVERITY; ECZEMA; ELECTRON MICROSCOPY; GENE MUTATION; GENE SEQUENCE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBLOTTING; MALE; MAMMAL; MEGAKARYOCYTE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEM CELL; THROMBOCYTOPENIA; TWO HYBRID SYSTEM; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKAGE; YEAST;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CARRIER PROTEINS; FAMILY HEALTH; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MEGAKARYOCYTES; MUSCLE PROTEINS; MUTATION, MISSENSE; PEDIGREE; PROTEIN BINDING; PROTEINS; THROMBOCYTOPENIA; TWO-HYBRID SYSTEM TECHNIQUES; WISKOTT-ALDRICH SYNDROME PROTEIN;

MAMMALIA; VESPIDAE;

EID: 0037312567     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)01023-8     Document Type: Article

References (38)

1. Aldrich R.A., Steinberg A.G., Campbell D.C. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 13:1954;133-138.
2. Ochs H.D. The Wiskott-Aldrich syndrome. Clin Rev Allergy Immunol. 20:2001;61-86.
3. Villa A., Notarangelo L., Macchi P.et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 9:1995;414-417.
4. Perry G.S. 3rd, Spector B.D., Schuman L.M.et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr. 97:1980;72-78.
5. Parolini O., Ressmann G., Haas O.A.et al. X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med. 338:1998;291-295.
6. Peacocke M., Siminovitch K.A. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome. Proc Natl Acad Sci U S A. 84:1987;3430-3433.
7. Kwan S.P., Sandkuyl L.A., Blaese M.et al. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers. Genomics. 3:1988;39-43.
8. de Saint Basile G., Arveiler B., Fraser N.J.et al. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome. Lancet. 2:1989;1319-1321.
9. Derry J.M., Ochs H.D., Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 78:1994;635-644.
10. Zhu Q., Watanabe C., Liu T.et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia. WASP gene mutations, protein expression, and phenotype Blood. 90:1997;2680-2689.
11. Nonoyama S., Ochs H.D. Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease. Curr Opin Immunol. 10:1998;407-412.
12. Symons M., Derry J.M., Karlak B.et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 84:1996;723-734.
13. Kolluri R., Tolias K.F., Carpenter C.L., Rosen F.S., Kirchhausen T. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci U S A. 93:1996;5615-5618.
14. Aspenstrom P., Lindberg U., Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol. 6:1996;70-75.
15. Miki H., Miura K., Takenawa T. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15:1996;5326-5335.
16. Kato M., Miki H., Imai K.et al. Wiskott-Aldrich syndrome protein induces actin clustering without direct binding to Cdc42. J Biol Chem. 274:1999;27225-27230.
17. Rivero-Lezcano O.M., Sameshima J.H., Marcilla A., Robbins K.C. Physical association between Src homology 3 elements and the protein product of the c-Cbl proto-oncogene. J Biol Chem. 269:1994;17363-17366.
18. Banin S., Truong O., Katz D.R., Waterfield M.D., Brickell P.M., Gout I. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol. 6:1996;981-988.
19. Cory G.O., MacCarthy-Morrogh L., Banin S.et al. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol. 157:1996;3791-3795.
20. Finan P.M., Soames C.J., Wilson L.et al. Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J Biol Chem. 271:1996;26291-26295.
21. Imai K., Nonoyama S., Miki H.et al. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton. Clin Immunol. 92:1999;128-137.
22. Callebaut I., Cossart P., Dehoux P. EVH1/WH1 domains of VASP and WASP proteins belong to a large family including Ran-binding domains of the RanBP1 family. FEBS Lett. 441:1998;181-185.
23. Ramesh N., Anton I.M., Hartwig J.H., Geha R.S. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci U S A. 94:1997;14671-14676.
24. Stewart D.M., Tian L., Nelson D.L. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J Immunol. 162:1999;5019-5024.
25. Anton I.M., Lu W., Mayer B.J., Ramesh N., Geha R.S. The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J Biol Chem. 273:1998;20992-20995.
26. Drachman J.G., Sabath D.F., Fox N.E., Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 89:1997;483-492.
27. Drachman J.G., Rojnuckarin P., Kaushansky K. Thrombopoietin signal transduction. studies from cell lines and primary cells Methods. 17:1999;238-249.
28. Shcherbina A., Rosen F.S., Remold-O'Donnell E. WASP levels in platelets and lymphocytes of Wiskott-Aldrich syndrome patients correlate with cell dysfunction. J Immunol. 163:1999;6314-6320.
29. Dyson P.G., Jackson K.A., McClure B.J., Rawling T.P., To L.B. Increased levels of megakaryocyte progenitors in peripheral blood mobilised by chemotherapy and/or haemopoietic growth factor protocols. Bone Marrow Transplant. 18:1996;705-712.
30. Nichols K.E., Crispino J.D., Poncz M.et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 24:2000;266-270.
31. Freson K., Devriendt K., Matthijs G.et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 98:2001;85-92.
32. Mehaffey M.G., Newton A.L., Gandhi M.J., Crossley M., Drachman J.G. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 98:2001;2681-2688.
33. Yu C., Niakan K.K., Matsushita M., Stamatoyannopoulos G., Orkin S.H., Raskind W.H. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 100:2002;2040-2045.
34. Haddad E., Cramer E., Riviere C.et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood. 94:1999;509-518.
35. Remold-O'Donnell E., Cooley J., Shcherbina A.et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol. 158:1997;4021-4025.
36. Thompson L.J., Lalloz M.R., Layton D.M. Unique and recurrent WAS gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis. 25:1999;218-226.
37. Steinberg M.H. Modulation of the phenotypic diversity of sickle cell anemia. Hemoglobin. 20:1996;1-19.
38. Summers K.M. Relationship between genotype and phenotype in monogenic diseases. relevance to polygenic diseases Hum Mutat. 7:1996;283-293.